Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast Cancer
Clinical trial NCT02562118 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02562118
- Sponsor
- National University Hospital, Singapore
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-02
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.